Leuprorelin acetate Prescribing at ALREWAS
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
83
Total Quantity
83
NHS Cost
£12.1K
vs National Avg
+79.1%
ALREWAS prescribed 83 items of Leuprorelin acetate over the last 12 months at a cost of £12,099 to the NHS. This is 79.1% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
11
Jun 2026
7
Jun 2026
1
Jun 2026
9
Jun 2026
4
Jun 2026
1
Jun 2026
9
Jun 2026
8
Jun 2026
14
Jun 2026
2
Jun 2026
17
Prescribing Details
| Total Items | 83 |
|---|---|
| Total Quantity | 83 |
| Total NHS Cost | £12,099 |
| Presentations | 3 different forms |
| vs National Average | +79.1% |
Leuprorelin acetate Prescribing Comparison
| This practice | 83 items |
|---|---|
| National average per practice | 46 items |
| Difference | +79.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.